---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-048516"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:34:36.501889+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# InfuSystem Q3 2025 revenue $36.5M (+3% YoY), net income $2.3M (+25%), reaffirms 2025 guidance

## Summary
- Net revenues $36.5M (record), up 3% vs. $35.3M a year ago; Patient Services up 8%, Device Solutions down 3%.
- Net income $2.3M ($0.11 diluted EPS) vs. $1.8M ($0.08) prior year, a 25% increase.
- Adjusted EBITDA $8.3M (+6%), margin 22.8% (up 0.5pp); YTD operating cash flow $17.3M (+38%).
- Wound care revenue surged 115% YoY ($1.0M); new contract with large hospital system and payer extension secured.
- Reaffirms full-year 2025 guidance: net revenue growth 6-8%, Adjusted EBITDA margin 20%+.

## SEC filing metadata
- accession: 0001628280-25-048516
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828025048516/0001628280-25-048516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828025048516/infu-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-048516
- JSON: https://secwatch.observer/filing/0001628280-25-048516.json
- Plain text: https://secwatch.observer/filing/0001628280-25-048516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.